tiprankstipranks
Fate upgraded to Neutral at BofA after FT819 achieves DORIS remission
PremiumThe FlyFate upgraded to Neutral at BofA after FT819 achieves DORIS remission
1M ago
Fate Therapeutics upgraded to Neutral from Underperform at BofA
Premium
The Fly
Fate Therapeutics upgraded to Neutral from Underperform at BofA
1M ago
Stifel ‘impressed’ with results for Fate Therapeutics’ first FT819 LN patient
Premium
The Fly
Stifel ‘impressed’ with results for Fate Therapeutics’ first FT819 LN patient
1M ago
Fate Therapeutics reports Q3 EPS (40c), consensus (43c)
PremiumThe FlyFate Therapeutics reports Q3 EPS (40c), consensus (43c)
1M ago
Is FATE a Buy, Before Earnings?
Premium
Pre-Earnings
Is FATE a Buy, Before Earnings?
2M ago
Fate Therapeutics Strengthens Legal Safeguards for Leadership
Premium
Company Announcements
Fate Therapeutics Strengthens Legal Safeguards for Leadership
4M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
5M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
5M ago
Intellia Therapeutics CFO Glenn Goddard to step down, Edward Dulac to succeed
Premium
The Fly
Intellia Therapeutics CFO Glenn Goddard to step down, Edward Dulac to succeed
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100